✦ LIBER ✦

Effects of treatment with etidronate and alfacalcidol for osteogenesis imperfecta type I: a case report

✍ Scribed by Jun Iwamoto; Kenjiro Matsu; Tsuyoshi Takeda; Shoichi Ichimura; Mitsuyoshi Uzawa

Publisher: Springer Japan
Year: 2003
Tongue: English
Weight: 173 KB
Volume: 8
Category: Article
ISSN: 0949-2658
DOI: 10.1007/s007760300042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Substitution of arginine for glycine at

Substitution of arginine for glycine at position 154 of the α1 chain of type I collagen in a variant of osteogenesis imperfecta: Comparison to previous cases with the same mutation

✍ Zhuang, Jiapiao; Tromp, Gerard; Kuivaniemi, Helena; Castells, Salvador; Prockop, 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 33 KB 👁 1 views

A substitution of arginine for glycine at amino acid position 154 of the al(1) collagen chain was found in a father and his three children. The phenotype of the patients includes manifestations of types I and IIUIV osteogenesis imperfecta, but appears to be milder than that of the previously describ

Mutation in the carboxy-terminal propept

Mutation in the carboxy-terminal propeptide of the proα1 (I) chain of type I collagen in a child with severe osteogenesis imperfecta (OI type III): Possible implications for protein folding

✍ Jane E. Oliver; Elizabeth M. Thompson; F. Michael Pope; Alan C. Nicholls 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 845 KB

A young girl presented with severe type 111 osteogenesis imperfecta; her otherwise healthy mother also had a mild connective tissue disorder with blue sclerae and recurrent joint dislocations. Skin fibroblast cultures from the child produced both normal and post-translationally overmodified type I c

Consortium for osteogenesis imperfecta m

Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans

✍ Joan C. Marini; Antonella Forlino; Wayne A. Cabral; Aileen M. Barnes; James D. S 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB

Osteogenesis imperfecta (OI) is a generalized disorder of connective tissue characterized by fragile bones and easy susceptibility to fracture. Most cases of OI are caused by mutations in type I collagen. We have identified and assembled structural mutations in type I collagen genes (COL1A1 and COL1

Direct sequencing of PCR products derive

Direct sequencing of PCR products derived from cDNAs for the proα1 and proα2 chains of type I procollagen as a screening method to detect mutations in patients with osteogenesis imperfecta

✍ Jiapiao Zhuang; Gerard Tromp; Helena Kuivaniemi; Salvador Castells; Merete Bugge 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 1004 KB

Communicated by Cha& I. Epstein More than 150 mutations in the genes for type I procollagein have been found in unrelated patients with osteogenesis imperfecta (01), but mutations have been difficult to define in many patients with the mildest forms of the disease. Here, we have used robotically aut